Your browser doesn't support javascript.
loading
Nivolumab-associated DRESS in a genetic susceptible individual.
Ai, Luoyan; Gao, Jie; Zhao, Shihai; Li, Qian; Cui, Yue-Hong; Liu, Qing; Wu, Duojiao; Wang, Yimei; Jin, Xiaoshi; Ji, Yuan; Li, Jingjie; Yu, Yiyi; Liu, Tianshu.
Afiliación
  • Ai L; Department of Medical Oncology, Zhongshan Hospital Fudan University, Shanghai, China.
  • Gao J; Cancer Center, Zhongshan Hospital Fudan University, Shanghai, China.
  • Zhao S; Department of Medical Oncology, Zhongshan Hospital Fudan University, Shanghai, China.
  • Li Q; Cancer Center, Zhongshan Hospital Fudan University, Shanghai, China.
  • Cui YH; Department of Radiology, Zhongshan Hospital Fudan University, Shanghai, China.
  • Liu Q; Department of Medical Oncology, Zhongshan Hospital Fudan University, Shanghai, China.
  • Wu D; Cancer Center, Zhongshan Hospital Fudan University, Shanghai, China.
  • Wang Y; Department of Medical Oncology, Zhongshan Hospital Fudan University, Shanghai, China.
  • Jin X; Cancer Center, Zhongshan Hospital Fudan University, Shanghai, China.
  • Ji Y; Department of Medical Oncology, Zhongshan Hospital Fudan University, Shanghai, China.
  • Li J; Cancer Center, Zhongshan Hospital Fudan University, Shanghai, China.
  • Yu Y; Department of Medical Oncology, Zhongshan Hospital Fudan University, Shanghai, China.
  • Liu T; Cancer Center, Zhongshan Hospital Fudan University, Shanghai, China.
J Immunother Cancer ; 9(10)2021 10.
Article en En | MEDLINE | ID: mdl-34599025

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Eosinofilia / Síndrome de Hipersensibilidad a Medicamentos / Nivolumab / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Predisposición Genética a la Enfermedad / Eosinofilia / Síndrome de Hipersensibilidad a Medicamentos / Nivolumab / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: China